Abstract

BackgroundContinuous passive motion (CPM) is a common procedure in total knee replacement (TKR), but its effectiveness is controversial at early stage after TKR. Some studies have claimed that CPM promoting...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
AB1232-HPR The effect of the drainage on proprioceptive acuity inpatients with total knee prosthesis
M Eymir ... V Karatosun
Annals of the Rheumatic Diseases | VOL. 76
M Eymir, et. al.M Eymir ... V Karatosun
01 Jun 2017
Comparison of early postoperative functional activity levels of patients undergoing unilateral and bilateral total knee arthroplasty
Serkan Bakirhan
Acta Orthopaedica et Traumatologica Turcica | VOL. 43
Serkan BakirhanSerkan Bakirhan
01 Jan 2009
FRI0532 Relationship between patient-reported outcomes and proprioceptive acuity in patients with total knee arthroplasty
M Eymir ... V Karatosun
Annals of the Rheumatic Diseases | VOL. 77
M Eymir, et. al.M Eymir ... V Karatosun
01 Jun 2018
FRI0620-HPR Efficacy of Local Infiltration Analgesia in Total Knee Arthroplasty: A Randomised, Placebo-Controlled, Double-Blind Trial
B Unver ... S Kalkan
Annals of the Rheumatic Diseases | VOL. 75
B Unver, et. al.B Unver ... S Kalkan
01 Jun 2016
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers